guest ::
| Home > Publications database > Prognostic biomarkers for survival in mucosal melanoma. > print |
| 001 | 277316 | ||
| 005 | 20240229155014.0 | ||
| 024 | 7 | _ | |a 10.1111/pcmr.13104 |2 doi |
| 024 | 7 | _ | |a pmid:37390098 |2 pmid |
| 024 | 7 | _ | |a 1755-1471 |2 ISSN |
| 024 | 7 | _ | |a 0893-5785 |2 ISSN |
| 024 | 7 | _ | |a 1600-0749 |2 ISSN |
| 024 | 7 | _ | |a 1755-148X |2 ISSN |
| 024 | 7 | _ | |a altmetric:150800031 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2023-01334 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Thierauf, Julia C |0 0000-0002-9607-3866 |b 0 |e First author |
| 245 | _ | _ | |a Prognostic biomarkers for survival in mucosal melanoma. |
| 260 | _ | _ | |a Oxford [u.a.] |c 2023 |b Wiley-Blackwell |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1692801081_16395 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A102# / 2023 Sep;36(5):378-387 |
| 520 | _ | _ | |a Mucosal melanoma (MM) is a rare subtype of melanoma with an aggressive clinical course. In cutaneous melanoma (CM), the absence of pigmentation and presence of NRAS/KRAS mutations are biomarkers indicating an aggressive clinical course with shorter overall survival. Similar data for MM are missing. We present the real-world outcome data in a cohort of genotyped MM patients and assessed the prognostic relevance of pigmentation- and NRAS/KRAS mutation status. We correlated pathological reports and clinical data with overall survival of patients with MM. Furthermore, we performed clinically integrated molecular genotyping and analyzed real world treatment regimens for covariates associated with clinical outcome. We identified 39 patients with available clinical and molecular data. Patients with amelanotic MM had a significantly shorter overall survival (p = .003). In addition, the presence of a NRAS or KRAS mutation was significantly associated with poor overall survival (NRAS or KRAS p = .024). Currently, it is unknown if the same prognostic relevance for the lack of pigmentation and RAS mutations in CM, exists in MM. Here we analyzed a cohort of MM for outcome measures and determined that two known prognostic biomarkers for CM are in fact novel prognosticators for MM. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a genotyping |2 Other |
| 650 | _ | 7 | |a mucosal melanoma |2 Other |
| 650 | _ | 7 | |a pigmentation |2 Other |
| 650 | _ | 7 | |a prognostic biomarkers |2 Other |
| 700 | 1 | _ | |a Kaluziak, Stefan T |b 1 |
| 700 | 1 | _ | |a Codd, Elizabeth |b 2 |
| 700 | 1 | _ | |a Dybel, Stacy N |b 3 |
| 700 | 1 | _ | |a Jobbagy, Soma |b 4 |
| 700 | 1 | _ | |a Purohit, Rashi |b 5 |
| 700 | 1 | _ | |a Farahani, Alex A |b 6 |
| 700 | 1 | _ | |a Dedeilia, Aikaterini |b 7 |
| 700 | 1 | _ | |a Naranbhai, Vivek |b 8 |
| 700 | 1 | _ | |a Hoang, Mai P |b 9 |
| 700 | 1 | _ | |a Fisch, Adam S |0 0000-0002-4742-8165 |b 10 |
| 700 | 1 | _ | |a Ritterhouse, Lauren |b 11 |
| 700 | 1 | _ | |a Boland, Genevieve M |b 12 |
| 700 | 1 | _ | |a Lennerz, Jochen K |b 13 |
| 700 | 1 | _ | |a Iafrate, A John |b 14 |
| 773 | _ | _ | |a 10.1111/pcmr.13104 |g p. pcmr.13104 |0 PERI:(DE-600)2425880-5 |n 5 |p 378-387 |t Pigment cell & melanoma research |v 36 |y 2023 |x 1755-1471 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:277316 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 0000-0002-9607-3866 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2022-11-29 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-29 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-25 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-25 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |d 2023-10-25 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b PIGM CELL MELANOMA R : 2022 |d 2023-10-25 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-10-25 |
| 920 | 1 | _ | |0 I:(DE-He78)A102-20160331 |k A102 |l Molekulare Grundlagen von HNO-Tumoren |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)A102-20160331 |k A102 |l Molekulare Grundlagen von HNO-Tumoren |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A102-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|